(19)
(11) EP 4 584 289 A2

(12)

(88) Date of publication A3:
20.06.2024

(43) Date of publication:
16.07.2025 Bulletin 2025/29

(21) Application number: 23776087.1

(22) Date of filing: 08.09.2023
(51) International Patent Classification (IPC): 
C07K 16/00(2006.01)
C12N 9/00(2006.01)
C07K 16/28(2006.01)
C12N 15/11(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 2317/92; C07K 2317/565; C07K 2317/567; C07K 16/00; C07K 16/2863; C12N 9/93
(86) International application number:
PCT/GB2023/052329
(87) International publication number:
WO 2024/052694 (14.03.2024 Gazette 2024/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 09.09.2022 GB 202213242

(71) Applicant: UEA Enterprises Limited
Norwich NR4 7TJ (GB)

(72) Inventors:
  • SACHDEVA, Amit
    Norwich NR4 7TJ (GB)
  • BRIDGE, Thomas
    Norwich NR4 7TJ (GB)
  • WEGMANN, Udo
    Norwich NR4 7TJ (GB)

(74) Representative: Appleyard Lees IP LLP 
15 Clare Road
Halifax HX1 2HY
Halifax HX1 2HY (GB)

   


(54) THERAPEUTIC MOLECULES